🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
SymBio Pharmaceuticals Limited (TYO:4582)
Japan flag Japan · Delayed Price · Currency is JPY
69.00
-9.00 (-11.54%)
Nov 20, 2026, 3:30 PM JST

SymBio Pharmaceuticals Balance Sheet

Millions JPY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
253.992,8833,9636,5176,2823,860
Cash & Short-Term Investments
253.992,8833,9636,5176,2823,860
Cash Growth
-92.67%-27.25%-39.19%3.74%62.74%0.30%
Accounts Receivable
181.852594239132,0842,148
Receivables
181.852594239132,0842,148
Inventory
98.63288238232469385.68
Prepaid Expenses
157.0460110119209145.01
Other Current Assets
200.03334190301268209.53
Total Current Assets
891.533,8244,9248,0829,3126,748
Property, Plant & Equipment
----6983.64
Long-Term Investments
0.0238448785-
Other Intangible Assets
----222259.1
Long-Term Deferred Tax Assets
3.465--7441,276
Other Long-Term Assets
37.35--1186.66
Total Assets
932.363,8674,9688,17010,4338,453

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1,200---4669.68
Accrued Expenses
-----516.04
Current Portion of Long-Term Debt
800682----
Current Income Taxes Payable
129.865867378721,564383.6
Other Current Liabilities
93.27222984313548.79
Total Current Liabilities
2,2231,2907669561,9231,518
Long-Term Debt
-1,300----
Pension & Post-Retirement Benefits
5.2744332.78
Other Long-Term Liabilities
-3312186.44
Total Liabilities
2,2282,5977739601,9281,707

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
20,44919,24418,33617,95217,54817,158
Additional Paid-In Capital
20,42419,21818,31117,92717,52317,133
Retained Earnings
-42,342-37,461-32,685-28,852-26,889-27,978
Treasury Stock
-89.89-89-89-89-88-86.05
Comprehensive Income & Other
262.59358322272411519.1
Shareholders' Equity
-1,2961,2704,1957,2108,5056,746
Total Liabilities & Equity
932.363,8674,9688,17010,4338,453

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
8001,982----
Net Cash (Debt)
-546.019013,9636,5176,2823,860
Net Cash Growth
--77.27%-39.19%3.74%62.74%0.30%
Net Cash Per Share
-7.8717.9487.88163.32158.6299.38
Filing Date Shares Outstanding
84.4671.7847.8344.7539.5238.37
Total Common Shares Outstanding
84.4659.4845.8442.1939.5238.37
Working Capital
-1,3312,5344,1587,1267,3895,230
Book Value Per Share
-15.3421.3591.52170.89215.22175.78
Tangible Book Value
-1,2961,2704,1957,2108,2836,487
Tangible Book Value Per Share
-15.3421.3591.52170.89209.60169.03
Buildings
-----64.62
Machinery
-----72.73